Thyrocare Technologies Ltd - 539871 - Intimation Under Regulation 31A(8)(C) Of The SEBI (Listing Obligations And Disclosure Requirements),Regulations 2015
Company has submitted the application for seeking the reclassification of promoter and promoter group in accordance with Regulation 31A of the Listing Regulations (more particularly Regulation 31A(10) of the Listing Regulations.) Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Trustee Services Ltd Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 17, 2021 for Docon Technologies Pvt Ltd Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 17, 2021 for Docon Technologies Pvt Ltd PharmEasy parent API Holdings appoints five independent directors
The move comes against the backdrop of Thyrocare stake acquisition Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 04, 2021 for Docon Technologies Pvt Ltd Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 04, 2021 for Docon Technologies Pvt Ltd Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & API Holdings Pvt Ltd Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. A Velumani & Others Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Outcome Of Board Meeting Held On 2 September 2021
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the Securities and Exchange Board of India circular dated 9 September 2015 bearing reference no. CIR/CFD/CMD/4/2015.